Hemp Enforcement, Modernization, and Protection Act

HR 7212 establishes a federal regulatory framework under the Food, Drug, and Cosmetic Act for "cannabinoid hemp products," directly affecting their manufacturers, distributors, retailers, and consumers. It mandates FDA registration for facilities and product listing, along with adherence to new manufacturing, testing, and labeling requirements for oral, inhalable, and topical cannabinoid hemp products. Key provisions include setting cannabinoid content limits, prohibiting certain ingredients and marketing practices (like appealing to children), requiring child-resistant packaging, and establishing a minimum purchase age of 21. The bill grants the FDA authority to enforce these rules through mandatory recalls, refusal of non-compliant imports, and penalties for violations, including selling "prohibited cannabinoid products" or to underage individuals. Additionally, it creates an advisory committee to provide recommendations on cannabinoid content limits and other regulatory matters.